Molecular Characterization of Spinal Tissue
| Status: | Enrolling by invitation |
|---|---|
| Conditions: | Orthopedic |
| Therapuetic Areas: | Orthopedics / Podiatry |
| Healthy: | No |
| Age Range: | 1 - 80 |
| Updated: | 3/21/2019 |
| Start Date: | March 31, 2015 |
| End Date: | January 1, 2021 |
The researchers are trying to identify molecular mechanisms that control spine deformity and
degenerative changes that can be used for therapeutic strategies.
degenerative changes that can be used for therapeutic strategies.
Discarded surgical material from spinal procedures is collected. RNA analysis and other tests
on the tissue is performed to determine markers of pathologic disease and to develop
pharmacologic treatment strategies for pediatric spinal disorders.
on the tissue is performed to determine markers of pathologic disease and to develop
pharmacologic treatment strategies for pediatric spinal disorders.
Inclusion Criteria:
- Children and adults undergoing surgical procedures where spinal tissues are removed as
a normal part of their procedure. Material from adults may be collected as a control
group.
Exclusion Criteria:
- Surgeries where spinal tissues are not being removed.
We found this trial at
1
site
Click here to add this to my saved trials
